Alpha Tau Medical Warrant
DRTSW
28 hedge funds and large institutions have $1.54M invested in Alpha Tau Medical Warrant in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 6 closing their positions.
19% more capital invested
Capital invested by funds: $1.3M → $1.54M (+$241K)
0.95% more ownership
Funds ownership: 4.76% → 5.71% (+0.95%)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
13% less funds holding
Funds holding: 32 → 28 (-4)
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCP
Corbin Capital Partners
New York
|
+$217K |
| 2 |
ACM
Atalaya Capital Management
New York
|
+$61.6K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$6.87K |
| 4 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$4.13K |
| 5 |
PA
Parallel Advisors
San Francisco,
California
|
+$1.71K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Balyasny Asset Management
Chicago,
Illinois
|
-$29K |
| 2 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$24.4K |
| 3 |
Two Sigma Investments
New York
|
-$8.76K |
| 4 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$6.64K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$5.65K |
DRTSW Hedge Fund Activity: Q2 2023 in Review
28 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Alpha Tau Medical Warrant (DRTSW) for Q2 2023, worth a combined $1.54M — up 19% from $1.3M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of DRTSW and 2 opened new positions — a net loss of 4 holders — while 3 trimmed existing stakes and 3 added.
The largest buyer was Corbin Capital Partners, adding an estimated $217K. The largest seller was Balyasny Asset Management, exiting entirely with an estimated $29K sold.
- 28 institutional investors held Alpha Tau Medical Warrant (DRTSW) as of Q2 2023, down from 32 in Q1 2023.
- Funds reported $1.54M of Alpha Tau Medical Warrant stock for Q2 2023, up 19% quarter-over-quarter.
- 2 funds opened new Alpha Tau Medical Warrant positions in Q2 2023 and 6 closed out, a net change of -4 holders.
- The largest Alpha Tau Medical Warrant buyer in Q2 2023 was Corbin Capital Partners, an estimated $217K added.
- The largest Alpha Tau Medical Warrant seller in Q2 2023 was Balyasny Asset Management, an estimated $29K sold.
Based on aggregated 13F filings for Q2 2023.